Area of research
Oncology · Immunology
Research interest
Research focused on Chimeric antigen receptor and Cancer research, with related work in CD28, Mesothelin, Myeloid leukemia. Notable publications include 'Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer', 'BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia', and 'Co-expression of a PD-L1-specific chimeric switch receptor augments the efficacy and persistence of CAR T cells via the CD70-CD27 axis'.
BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia
Co-expression of a PD-L1-specific chimeric switch receptor augments the efficacy and persistence of CAR T cells via the CD70-CD27 axis
Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels
Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer